Person profile
Address
South San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Prelude Therapeutics Inc
18 Jun 24
4
Oric Pharmaceuticals, Inc.
14 Jun 24
3
MADRIGAL PHARMACEUTICALS, INC.
21 Mar 24
4
Prelude Therapeutics Inc
21 Jun 23
4
Oric Pharmaceuticals, Inc.
15 Jun 23
4
ACELYRIN, Inc.
11 May 23
4
ACELYRIN, Inc.
4 May 23
3
ACELYRIN, Inc.
4 May 23
4
Ultragenyx Pharmaceutical Inc.
17 Oct 22
4
Ultragenyx Pharmaceutical Inc.
14 Oct 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Jun 24 | PRLD Prelude Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 3.9 | 23,500 | 91.65 k | 23,500 |
12 Jun 24 | ORIC ORIC Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 7.9 | 25,600 | 202.24 k | 25,600 |
16 Jun 23 | PRLD Prelude Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 5.56 | 23,500 | 130.66 k | 23,500 |
14 Jun 23 | ORIC ORIC Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 6.33 | 20,500 | 129.77 k | 20,500 |